Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

mAbs

Showing results (1081-1090 of 1,834) with videos related to

Pageof 184
Sort By:
Mabs|January 14, 2010
Guardians at the gate: patent protection of therapeutic monoclonal antibodies through product life cycle management--Part 3Kevin W McCabe, Paul A Calvo
Mabs|January 14, 2010
Preclinical evaluation of light-activatable, bispecific anti-human CD3 antibody conjugates as anti-ovarian cancer therapeuticsStephen Thompson, John Dessi, Colin H Self
Mabs|January 15, 2010
UstekinumabOya Cingoz
Mabs|January 5, 2010
Combination bortezomib and rituximab treatment affects multiple survival and death pathways to promote apoptosis in mantle cell lymphomaLapo Alinari, Valerie L White, Christian T Earl, et al.
Mabs|January 5, 2010
Global antibody development trendsJanice M Reichert
Mabs|April 17, 2019
Effects of terminal galactose residues in mannose α1-6 arm of Fc-glycan on the effector functions of therapeutic monoclonal antibodiesMichihiko Aoyama, Noritaka Hashii, Wataru Tsukimura, et al.
Mabs|September 20, 2018
Systematic development of temperature shift strategies for Chinese hamster ovary cells based on short duration cultures and kinetic modelingJianlin Xu, Peifeng Tang, Andrew Yongky, et al.
Mabs|September 26, 2018
Monovalent TNF receptor 1-selective antibody with improved affinity and neutralizing activityFabian Richter, Kirstin A Zettlitz, Oliver Seifert, et al.
Mabs|August 16, 2018
Homology modeling and structure-based design improve hydrophobic interaction chromatography behavior of integrin binding antibodiesArif Jetha, Nels Thorsteinson, Yazen Jmeian, et al.
Mabs|July 7, 2017
Pharmacokinetics of an intracerebroventricularly administered antibody in ratsYuki Noguchi, Motohiro Kato, Kazuhisa Ozeki, et al.
Pageof 184

Showing results (1081-1090 of 1,834) with videos related to

Sort By:
Pageof 184
Mabs|January 14, 2010
Guardians at the gate: patent protection of therapeutic monoclonal antibodies through product life cycle management--Part 3Kevin W McCabe, Paul A Calvo
Mabs|January 14, 2010
Preclinical evaluation of light-activatable, bispecific anti-human CD3 antibody conjugates as anti-ovarian cancer therapeuticsStephen Thompson, John Dessi, Colin H Self
Mabs|January 15, 2010
UstekinumabOya Cingoz
Mabs|January 5, 2010
Combination bortezomib and rituximab treatment affects multiple survival and death pathways to promote apoptosis in mantle cell lymphomaLapo Alinari, Valerie L White, Christian T Earl, et al.
Mabs|January 5, 2010
Global antibody development trendsJanice M Reichert
Mabs|April 17, 2019
Effects of terminal galactose residues in mannose α1-6 arm of Fc-glycan on the effector functions of therapeutic monoclonal antibodiesMichihiko Aoyama, Noritaka Hashii, Wataru Tsukimura, et al.
Mabs|September 20, 2018
Systematic development of temperature shift strategies for Chinese hamster ovary cells based on short duration cultures and kinetic modelingJianlin Xu, Peifeng Tang, Andrew Yongky, et al.
Mabs|September 26, 2018
Monovalent TNF receptor 1-selective antibody with improved affinity and neutralizing activityFabian Richter, Kirstin A Zettlitz, Oliver Seifert, et al.
Mabs|August 16, 2018
Homology modeling and structure-based design improve hydrophobic interaction chromatography behavior of integrin binding antibodiesArif Jetha, Nels Thorsteinson, Yazen Jmeian, et al.
Mabs|July 7, 2017
Pharmacokinetics of an intracerebroventricularly administered antibody in ratsYuki Noguchi, Motohiro Kato, Kazuhisa Ozeki, et al.
Pageof 184